1. AWMF (2016) AWMF-Leitlinie 015-006; Leitlinienklasse S2e: Diagnostik und Therapie des weiblichen Deszensus genitalis. (April 2016; V. 1.1)
2. Basu M, Wise B, Duckett J (2011) A qualitative study of women’s preferences for treatment of pelvic floor disorders. BJOG 118(3):338–344
3. Dällenbach P (2015) To mesh or not to mesh: a review of pelvic organ reconstructive surgery. Int J Womens Health 7:331–343
4. FDA Public (1999) Guidance for Industry and/or for FDA Reviewers/Staff and/or Compliance Guidance for the Preparation of a Premarket Notification Application for a Surgical Mesh – Document issued on: March 2, 1999.
https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm073791.pdf
5. FDA Public (2008) Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence; Issued: October 20, 2008.
https://thegloriosolawfirm.com/fda-public-health-notification-serious-complications-associated-with-transvaginal-placement-of-surgical-mesh-in-repair-of-pelvic-organ-prolapse-and-stress-urinary-incontinence/